DOE P 434.1, Conduct and Approval of Select Agent and Toxin Work at Department of Energy Sites
Functional areas: Counterterrorism, Safety
The purpose of this policy is to establish the Departments expectations for the establishment and operation of DOE research laboratories utilizing select agents and toxins (as regulated by the United States Department of Health and Human Services), hereinafter called LABS, and to ensure future policy needs for the operation, coordination, and oversight of these LABS. . Canceled by DOE P 434.1A.
Superseded By:
Version history and related documents
Superseded by
A newer version replaces this document.
Document text
Text extracted from the attached file. Refer to the original document for the authoritative version.
Section 1
AVAILABLE ONLINE AT: INITIATED BY:
www.directives.doe.gov Office of Health, Safety and Security
U.S. Department of Energy POLICY
Washington, D.C.
Approved: 6-5-09
SUBJECT: CONDUCT AND APPROVAL OF SELECT AGENT AND TOXIN WORK AT
DEPARTMENT OF ENERGY SITES
PURPOSE AND SCOPE
The Public Health Security and Bioterrorism Preparedness and Response Act of 2002 (Public
Law 107-188) directs the Secretary of Energy and the Administrator of the National Nuclear
Security Administration to expand, enhance, and intensify research relevant to the rapid
detection and identification of select agents and toxins likely to be used in a bioterrorism attack
or other select agents and toxins that may cause a public health emergency.
In meeting its obligations under the Public Health Security and Bioterrorism Preparedness and
Response Act, the Department of Energy (DOE) places a high priority on occupational health,
safety and security and emergency management, as well as its responsibility for protecting the
public and environment from any hazards resulting from these activities.
The purpose of this policy is to establish the Department’s expectations for the establishment and
operation of DOE research laboratories utilizing select agents and toxins (as regulated by the
United States Department of Health and Human Services), hereinafter called LABS, and to
ensure future policy needs for the operation, coordination, and oversight of these LABS.
POLICY
The Department will not authorize any biosafety level (BSL)-4 activity at LABS or allow BSL-4
operations to be conducted at DOE facilities or on DOE sites.
The Department will not authorize any laboratory operations with select agents and toxins
including those which may be part of classified Work for Others or similar projects (including
work involving Sensitive Compartmented Information (SCI) or Special Access Programs
(SAPs) without the head of the DOE field element being fully informed of the details of the
operations.
The Department will oversee and approve the building and operations of any DOE LABS.
All research activities performed by DOE or DOE contractors in LABS will comply with all
applicable DOE regulations and directives as well as other applicable federal, state, and local
regulations.
BSL-3 labs will follow current DOE procedures and policy. If necessary, DOE will establish
additional specific guidance to ensure safe construction and operation of BSL-3 LABS. Any
new construction of BSL-3 LABS must be conducted in accordance with DOE O 413.3A Chg 1,
Program and Project Management for the Acquisition of Capital Assets, dated 7-28-06, as
modified by Chg 1, dated 11-17-08.
DOE P 434.1
2 DOE P 434.1
6-5-09
DOE will develop a long-term strategy for Departmental coordination of current and future
research activity involving select agents and toxins. It will ensure a cooperative relationship is
developed with the United States Department of Health and Human Services and the United
States Department of Agriculture (USDA) in their regulatory oversight of DOE select agent and
toxin activities.
DOE will ensure that any agency requesting work be responsible for all costs incurred by DOE
contractor(s) performing work for that agency for which DOE is required to reimburse the
contractor(s). Such costs include any and all third party liability costs incurred by the contractor
and reimbursed by DOE in accordance with the “Insurance- litigation and claims” clause
Section 2
(DEAR 970.5228-1) contained in DOE’s contract with the contractor. To the extent that DOE
may incur any liabilities in regards to the performance of the work directly, DOE will ensure that
the agency requesting the work will reimburse DOE for such liabilities.
APPLICABILITY
This Policy applies to the development, construction, and operation of research laboratories
utilizing select agents and toxins.
RESPONSIBILITIES
1. The heads of the Program Secretarial Office (PSO) is responsible for the formal approval
of the establishment of any new BSL-3 research laboratory intended for conducting
research on or otherwise utilizing select agents and toxins.
2. The heads of DOE field elements are responsible for ensuring the full implementation of
this policy at the respective field facility.
3. The DOE Biosurety Executive Working Group, in concert with the Department of
Homeland Security and other federal agencies utilizing DOE laboratories, will be
responsible for developing a long-term strategy for research activities involving select
agents and toxins.
REFERENCES
• Public Law 91-190, National Environmental Policy Act (NEPA) of 1969, as amended,
codified at 42 U.S.C. Sections 4321-4347
• 7 CFR Part 331, “Possession, Use and Transfer of Select Agents and Toxins”
• 9 CFR Part 121, “Possession, Use and Transfer of Select Agents and Toxins”
• 42 CFR Part 72, “Interstate Shipment of Etiological Agents”
• 42 CFR Part 73, “Select Agents and Toxins”
• 42 CFR Part 1003, “Civil Money Penalties, Assessments and Exclusions”
DOE P 434.1 3 (and 4)
6-5-09
• 10 CFR Part 851, “Worker Safety and Health Program”, Appendix A, Section. 7,
“Biological Safety”
• Biosafety in Microbiological and Biomedical Laboratories (BMBL). 5
th
Edition. Centers
for Disease Control and Prevention
STEVEN CHU
Secretary of Energy